This study defines mechanisms that improve the host response in the absence of IL-27 signaling during neonatal sepsis and reinforces the potential for antagonizing IL-27 as a host-directed therapy for neonatal sepsis. The gene discussed is IL27; the disease is Neonatal sepsis.